Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant
1 clinical trials · Condition
◉ Watch Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant
| Record | Firm | Date |
|---|---|---|
| Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery (NCT02812420) | M.D. Anderson Cancer Center | 2017-03-07 |
Track Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant automatically
Every clearance here is in the API, with alerts when new ones post.